NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD) trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR-T therapy targets Hard-to-Treat brain autoimmune diseases
Disease control Not yet recruitingThis early-stage trial is testing a new treatment called C-CAR168, which uses a patient's own immune cells modified to attack harmful cells in the body. It is for 15 adults with multiple sclerosis, neuromyelitis optica, autoimmune encephalitis, or stiff person syndrome that have …
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)
Phase: PHASE1 • Sponsor: Huashan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a new drug ease nerve pain in a rare disease?
Symptom relief Not yet recruitingThis trial investigates whether the drug crisugabalin can reduce neuropathic pain in people with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune condition affecting the nerves. Participants will receive either crisugabalin or a placebo, and their pain levels wil…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS (NMOSD)
Phase: PHASE4 • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC